These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37504318)

  • 1. The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey.
    Al-Ezzi EM; Zahralliyali A; Hansen AR; Hamilton RJ; Crump M; Kuruvilla J; Wood L; Nappi L; Kollmannsberger CK; North SA; Winquist E; Soulières D; Hotte SJ; Jiang DM
    Curr Oncol; 2023 Jun; 30(7):6166-6176. PubMed ID: 37504318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
    Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy for relapsed testicular germ cell tumours.
    Chovanec M; Adra N; Abu Zaid M; Abonour R; Einhorn L
    Nat Rev Urol; 2023 Apr; 20(4):217-225. PubMed ID: 36477219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
    Selle F; Wittnebel S; Biron P; Gravis G; Roubaud G; Bui BN; Delva R; Bay JO; Fléchon A; Geoffrois L; Caty A; Soares DG; de Revel T; Fizazi K; Gligorov J; Micléa JM; Dubot C; Provent S; Temby I; Gaulet M; Horn E; Brindel I; Lotz JP
    Ann Oncol; 2014 Sep; 25(9):1775-1782. PubMed ID: 24894084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
    Connolly EA; Weickhardt A; Grimison P; Asher R; Heller GZ; Lewin J; Liow E; Toner G; Tung ILY; Tran B; Hill S; Walpole E; McKenzie J; Kuchel A; Goh J; Forgeson G; Tan A; Joshi A; Wickham A; Tan H; Wang Y; Winstanley MA; Hamad N; Wong V
    BJU Int; 2022 Jun; 130 Suppl 1():5-16. PubMed ID: 35355402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.
    Rashid S; Lim L; Powles T
    Curr Treat Options Oncol; 2012 Jun; 13(2):201-11. PubMed ID: 22623055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem cell transplantation for patients with extracranial germ cell tumors - experience of two Brazilian pediatric centers.
    Villela NC; Seber A; Macedo CRPD; Zecchin VG; Guimarães RFDC; Faria TMV; Vidal DO; Jorge GEM; Navarro G; Lopes LF
    Pediatr Hematol Oncol; 2023; 40(6):539-553. PubMed ID: 36940088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
    Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
    Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.
    De Giorgi U; Rosti G; Salvioni R; Papiani G; Ballardini M; Pizzocaro G; Marangolo M
    Urol Oncol; 2011; 29(3):284-90. PubMed ID: 19556152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
    J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
    Ferhatoglu F; Paksoy N; Khanmammadov N; Yildiz A; Ahmed MA; Gülbas Z; Basaran M
    Medicine (Baltimore); 2024 Feb; 103(8):e37213. PubMed ID: 38394499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage treatment for children with relapsed/refractory germ cell tumors: The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) experience.
    De Pasquale MD; D'Angelo P; Crocoli A; Boldrini R; Conte M; Bisogno G; Spreafico F; Inserra A; Biasoni D; Dall'Igna P; Siracusa F; Miele E; Terenziani M
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28125. PubMed ID: 31850649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
    Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
    Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L
    Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
    González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
    Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
    J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.